Evidence map›Paper›PMID 29270514›Full record

ArticleKidney international reports2017

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Theresa Ermer, Christoph Kopp, John R Asplin, Ignacio Granja, Mark A Perazella, Martin Reichel, Thomas D Nolin, Kai-Uwe Eckardt, Peter S Aronson, Fredric O Finkelstein and 1 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Diagnosis and management of primary hyperoxalurias: best practices.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  5. Observational
  6. Article
  7. Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Characterization of renal NaCl and oxalate transport in Slc26a6American journal of physiology. Renal physiology · 2019
    Article
  14. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Theresa ErmerDepartment of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Christoph KoppDepartment of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
John R AsplinLitholink Corporation, Laboratory Corporation of America Holdings, Chicago, Illinois, USA.
Ignacio GranjaLitholink Corporation, Laboratory Corporation of America Holdings, Chicago, Illinois, USA.
Mark A PerazellaDepartment of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.
Martin ReichelDepartment of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Thomas D NolinDepartment of Pharmacy and Therapeutics, Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kai-Uwe EckardtDepartment of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Peter S AronsonDepartment of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.
Fredric O FinkelsteinDepartment of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.
Felix KnaufDepartment of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEYale University · USLabCorp (United States) · USLink Foundation · USUniversity of Pittsburgh · US

Funding

Roles of SLC26A6 in Renal NaCI Transport and Prevention of Oxalate UrolithiasisR37DK033793 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 1994 to 2016
$6.8M
Roles of SLC26 Transporters in Urinary Oxalate Excretion and Kidney DiseaseR01DK033793 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 1986 to 2022
$5.6M
NIDDK NIH HHS R01 DK033793NIDDK NIH HHS R37 DK033793
6 · The paper itself

Abstract

introductionCalcium oxalate supersaturation is regularly exceeded in the plasma of patients with end-stage renal disease (ESRD). Previous reports have indicated that hemodialfiltration (HDF) lowers elevated plasma oxalate (P

methodsFourteen patients with ESRD who underwent HDF 3 times a week for 4 to 4.5 hours (regular HDF; n = 8) or 7 to 7.5 hours (extended HDF; n = 6) were changed to HD for 2 weeks and then back to HDF for another 2 weeks. P

resultsBaseline P DISCUSSION: In contrast to earlier observations, our data did not support a benefit of HDF over HD for P

Indexed as

clearance kineticsend-stage renal disease (ESRD)hemodialfiltration (HDF)hemodialysis (HD)oxalate

Identifiers

PMID29270514
PMCPMC5733827
OpenAlexW2624208195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.